Ravgen

About:

Ravgen is a biotechnology company that specializes in non-invasive prenatal diagnostic testing.

Twitter/X: RavgenDNA

Description:

Ravgen specializing in non-invasive prenatal genetic testing and paternity testing, Ravgen is focused on developing non-invasive prenatal diagnostic tests based on fetal DNA present in maternal blood. Diagnose single gene disorders, such as cystic fibrosis, sickle cell anemia and Downs syndrome, establish paternity and more early on in pregnancy.

Total Funding Amount:

$3.57M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Columbia, Maryland, United States

Founded Date:

2000-01-01

Contact Email:

info(AT)ravgen.com

Founders:

Ravinder Dhallan

Number of Employees:

1-10

Last Funding Date:

2021-06-03

IPO Status:

Private

Industries: